(
221
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Asthma endotypes as risk factors for severe COVID-19 manifestations
-
Asthma management during the COVID-19 pandemics
-
Can we identify patients at risk of life-threatening allergic reaction to food?
-
Challenges in food allergy management
-
Contraindications to venom immunotherapy and risk factors for adverse events: any left?
-
Diagnosis and Management of hypersensitivity to excipients
-
Dietary management of food allergy
-
Drugs as risk factors for allergic diseases
-
Exposome modulation and immunotherapy in infants at higher risk of respiratory allergies
-
Flash Talks on allergy management
-
Getting the diagnosis right is essential for optimal nutritional and dietary management of food allergy
-
Management of Chronic Urticaria and involving the patient
-
Management of asthma exacerbations
-
Management of drug allergy
-
May contain traces… management in children with food allergies
-
Novel insights into rhinitis management
-
Practical approach of diagnosis and management of not IgE mediated food allergies
-
Risk factors for conjunctivitis in atopic dermatitis patients treated with dupilumab: results from the bioday registry
-
Understanding immunological mechanisms that confer a higher risk of allergy
-
Update of pathogenesis and management of nasal polyposis
-
Utility of Molecular Allergology in supporting management of patients sensitised to cross-reactivity allergens
Show more Event Resources (19)Show Less-
-
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria Taskforce
-
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task Force
-
A systematic review and meta-analysis on absolute eosinophil counts and the risk of asthma in preschool children with wheezing: An EAACI Task Force Report
-
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) – a EAACI position paper
-
Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants – An EAACI Position Paper
-
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paper
-
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paper
-
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children – EAACI position paper
-
Diagnosis and management of food allergy-induced constipation in young children—An EAACI position paper
-
Diagnosis and management of the drug hypersensitivity reactions in coronavirus disease 19: An EAACI position paper
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
-
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
-
Management of anaphylaxis due to COVID-19 vaccines in the elderly
-
Management of ocular allergy
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper
-
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases
-
Pathogenesis, immunology, and immune-targeted management of the multisystem inflammatory syndrome in children (MIS-C) or pediatric inflammatory multisystem syndrome (PIMS): EAACI Position Paper
Show more Position Papers (15)Show Less-
-
African American children are at higher risk for COVID‐19 infection
-
Biologics increase the risk of SARS-CoV-2 infection and hospitalization, but not ICU admission and death: real-life data from a large cohort during RED-ZONE declaration
-
Characterization of asthma and risk factors for delayed SARS‐CoV‐2 clearance in adult COVID‐19 inpatients in Daegu
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccines
-
Genetic Predisposition to allergic diseases is inversely associated to risk of COVID-19
-
Management of patients with atopic dermatitis undergoing systemic therapy during COVID‐19 pandemic in Italy: data from the DA‐COVID‐19 registry
-
Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic – An EAACI Position Paper
-
Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemic
-
Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma Section
-
Risk factors for severe and critically ill COVID-19 patients: A review
-
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
Show more Covid-19 (9)Show Less-
-
Better defining the roles of non-allergy specialists healthcare professionals in the management of allergic disorders
-
Clinical diagnosis and management of severe cutaneous adverse drug reactions (SCARs) in children: an ENDA/EAACI pediatric task force report
-
EAACI position paper on the diagnosis and therapeutic management of allergic bronchopulmonary aspergillosis (ABPA)
-
Management of adverse reactions to anticoagulants
-
Recommendations for prevention and management of adverse reactions to biologics
-
Roadmap for the management of EoE
-
Understanding accidental food exposure risk in children and young people with food allergies in Europe
-
Updated guidelines on the risk assessment and methodology of skin tests for the investigation of drug allergy
-
Urticaria and anaphylaxis in endurance and ultra-endurance athletes: a proposal for pre-race risk assessment
-
Use of biologics in the management of rare eosinophilic diseases
Show more Task Forces (8)Show Less-
-
A New Age in the Management of Pediatric Atopic Dermatitis: Evolution of Disease Understanding and Treatment Opportunities
-
Activated phosphoinositide 3-kinase δ syndrome (APDS): Challenges in diagnosis, management and recent advances in treatment
-
Advancing the management of CMPA with HMO: Priming the immune system
-
Chronic spontaneous urticaria: defining the pathway to successful management
-
Relegating OCS to last resort: Creating a paradigm shift in asthma management
Show more Sponsored Symposia (3)Show Less-
-
Diagnosis and management of hypersensitivity reactions due to biologics
-
Food Allergy and Anaphylaxis: Latest updates in the diagnosis and management of food allergy
-
Management of Common Drug Allergies
-
Risk Factors, Triggers and Potential Biomarkers of Angioedema
-
Tips & Tricks and Tools for Angioedema Management in Routine Clinical Practice
Show more Courses (3)Show Less-
-
EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy
-
The international EAACI/ GA²LEN/ EuroGuiDerm/ APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
-
The international WAO/ EAACI guideline for the management of hereditary angioedema – The 2021 revision and update
Show more Guidelines (1)Show Less-
Website
Collapse
-
A more diverse diet in infancy associates with decreased food allergy risk at 18 months age
-
A stepwise approach to the management of a patient with celiac disease and multiple IgE-mediated food allergies
-
Adrenaline autoinjectors are essential for managing patients at risk of anaphylaxis
-
Adrenaline autoinjectors for people at risk of anaphylaxis
-
Advancements and Key Insights in Chronic Rhinosinusitis (CRS) Management
-
Advances in drug allergy diagnosis and management
-
Advancing AIT in the clinical management of children with respiratory allergy
-
Aerobiological patterns and allergy risk season in Talavera de la Reina (central Spain)
-
Allergen immunotherapy in patients with allergic rhinitis and asthma associated with reduced risk of severe COVID-19
-
Allergy to anesthetics: new insights in diagnosis and risk reduction
-
Anaphylaxis from shellfish and mollusks and cross-reactive allergies: the impact of ‘novel foods’ containing insect flours on sensitization and allergic risk in childre
-
Application of Smart Wearable Devices in Management of Asthma
-
Applying allergen threshold to dietary management of food allergy
-
Assessing risk for food challenges
-
Asthma Digital Health Tools and Opportunities for ArtificiaI Intelligence – Based Risk Prediction
-
Atopy as a reflection of inborn errors of immunity: strategies for effective management
-
Blueprint Medicines – Transforming management of indolent systemic mastocytosis with precision medicine
-
Breakthroughs in management of Hereditary Angioedema
-
Burden and subtypes of early-life infections increase the risk of asthma and adverse lung function
-
Can we identify patients at risk of life-threatening allergic reaction to food?
-
Challenges in Anaphylaxis management
-
Clinical and laboratory features of children at risk of local allergic rhinitis
-
Clinical characteristics and risk factors of allergic diseases in children after liver transplantation
-
Clinical profile and management of pediatric hereditary angioedema in resource constrained settings: our experience from a single centre in North India
-
Clinical profile and management of pediatric hereditary angioedema in resource constrained settings: our experience from a single centre in North India
-
Closing Remarks and Summary: Closing Gaps in HAE Management
-
Comparative Risk of Neuropsychiatric Adverse Events Associated With Leukotriene-Receptor Antagonists Versus Inhaled Corticosteroids Among Asthma Patients
-
Cow’s milk protein allergy is not a risk factor for early childhood caries
-
Current concepts on management of AD
-
DBV Technologies – Peanut allergy management in motion!
-
Detection and management of milk allergy
-
Development and Validation of a Clinical Risk Score to Predict Pediatric Atopic Dermatitis in Utero
-
Development and implementation of an intelligence platform for management of allergen immunotherapy in China
-
Diagnosis, management and follow-up of a fish FPIES series: room from improvement
-
Dietary management of food allergy: What do I do?
-
Do repeated COVID-19 vaccinations increase the risk of allergic adverse reactions?
-
EAACI & APAPARI joint symposium – Novel approaches to the management of fish allergy
-
Effect of the C-589T IL-4 gene SNP on risk of COVID-19 infection
-
Effects of hypoallergenic formula containing synbiotics in the management of cow’s milk allergy: results of a global healthcare professional and parent survey
-
Efficacy of Omalizumab in Food Allergy Management in a Patient with Chronic Spontaneous Urticaria
-
Emerging insights into food allergy mechanisms and clinical management
-
Evaluation of risk factors causing diagnostic delay in non-steroidal anti-inflammatory drug -exacerbated respiratory disease
-
Evolving Strategies in the Management of IgE-Mediated Egg Allergy: A Systematic Review
-
Exploring a beta-lactoglobulin-based food for specific medical purposes (FSMP) for dietary management of chronic inflammation in atopic dermatitis: insights from mouse studies
-
Exploring the impact of oncologic risk factors on severe COVID-19 outcomes through multiplatform metabolomics
-
Exploring the impact of oncologic risk factors on severe COVID-19 outcomes through multiplatform metabolomics
-
FPIES Management
-
FPIES diagnosis and management
-
Fish allergy and tolerance: a case of safe management thanks to multiplex MADX-ALEX2 test
-
Flash talks on Allergic Response Management
-
Food Allergy: From prevelance, therapeutic options and management of anaphylaxis.
-
G-1082A IL-10 gene polymorphism does not impact COVID 19 infection risk
-
Head-to-head comparison between allergist vs. non-allergist in low risk penicillin allergy delabelling: effectiveness, safety and impact on quality of life from a multi-centre, prospective cohort study in Hong Kong (HK-DADI2)
-
Head-to-head comparison between allergist vs. non-allergist in low risk penicillin allergy delabelling: effectiveness, safety and impact on quality of life from a multi-centre, prospective cohort study in Hong Kong (HK-DADI2)
-
Healthcare Provider Perspectives on Management of European Patients with Systemic Mastocytosis
-
Hereditary α-tryptasemia is associated with increased risk for drug-induced anaphylaxis
-
High burden of disease and risk of comorbidities in children with allergic rhinitis
-
Hymenoptera venom immunotherapy with 210 minutes Ultra-Rush protocol: patient profile and potential risk factors for systemic reactions
-
Impact of the new UK guidelines on the emergency management of anaphylaxis at two hospitals
-
Impact of variants in genes related to acetaminophen biodisposition on the risk of developing selective acetaminophen hypersensitivity
-
Improving NMBA hypersensitivity management using CD203c activation marker in basophil activation tests
-
Improving food allergy risk prediction using routinely collected electronic medical record data: Development and External Validation
-
Increased risk of wheezing and associated burden subsequent to respiratory syncytial virus (RSV) infection in a multi-country cross-sectional survey of parent’s perception
-
Infant feeding practices are related to the risk of food allergy: birth cohort study from a developing Asian country
-
Infection History and Risk of Chronic Inflammatory Airway Diseases; A Real-World Hospital Cohort Study
-
Infection History and Risk of Chronic Inflammatory Airway Diseases; A Real-World Hospital Cohort Study
-
Innovative treatments and strategies for food allergy management
-
Insights into Hereditary Angioedema management
-
Introduction of Allergy Screening in Germany: An Initiative for Early Identification and Targeted Care of Children at Increased Allergy Risk
-
Is hereditary alpha-tryptasemia truly a risk factor for anaphylaxis?
-
Is there still a role for oral corticosteroids in the management of CRS
-
Long-Term Dupilumab Treatment is Not Associated With an Increased Overall Risk of Infections in Patients Aged 6 Months to 5 Years With Moderate-to-Severe Atopic Dermatitis in an Open-Label Extension Study
-
Long-term effects of COVID-19 on the risk of ischemic heart disease in asthma: A nationwide, population-based cohort study
-
Low education level, occupational exposure and no medication use increase the risk of uncontrolled asthma in Chinese patients: findings from baseline data of a multi-centre, single-arm study (CARE FOR ALL)
-
Low fecal butyrate levels at the age of one year is associated with an increased risk of atopic dermatitis in early childhood
-
Management decisions in 13 patients with hypersensitivity reactions to chemotherapy agents
-
Management of Atopic dermatitis patients under the scope of Treat to target (T2T)– Real world data of remission induction stage
-
Management of Atopic dermatitis patients under the scope of Treat to target (T2T)– Real world data of remission induction stage
-
Management of adverse reactions to platinum based drugs in our unit in the last year
-
Management of allergic asthma
-
Management of allergic rhinitis in children
-
Management of cow’s milk allergy in children
-
Management of fish allergy based on Oral Food Challenge
-
Management of food allergy in the clinic
-
Management of reactions to chemotherapeutic drugs in children
-
Maternal Atopy May Be A Risk Factor For Pulmonary Airway Resistance In Wheezy Children
-
Maternal exercise during pregnancy is associated with reduced risk of asthma in the child: a prospective birth cohort study
-
Measurement of serum specific IgE to Ryegrass allergen component Lol p 5 in the TAISAR cohort predicts risk of Thunderstorm Asthma
-
Mechanisms and management of hypersensitivity induced by specific drugs
-
Mepolizumab significantly reduces clinical interventions in the management of patients with CRSwNP: post hoc analysis of SYNAPSE using a composite endpoint
-
Non IgE-mediated food allergy: from diagnosis to management – Session 1: Food protein-induced entrocolitis – FPIES
-
Non IgE-mediated food allergy: from diagnosis to management – Session 2: Eosinophilic esophagitis
-
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Hypersensitivity Reactions: An approach to assessment, diagnosis, and management in a paediatric population
-
Non-exclusive colostrum feeding is associated with an increased risk of food allergy in one-year-old-children
-
Novartis Pharma AG – Navigating the labyrinth of CSU management
-
Nutritional strategies and lifestyle management in food allergies
-
Obesity Modified the Genetic Effect on Risk of Asthma: A Genome-wide Association Study of Adult Asthma
-
Occupational risk factors for asthma-related outcomes in Tanzanian seaweed harvesting and processing workers
-
Omalizumab administration for the management of severe allergic keratoconjunctivitis – a 10-year experience
-
Optimising asthma management in children
-
PDS3: Food Allergy Management 2
-
PDS6: Food Allergy Management 1
-
PEN-FAST score performances to evaluate the risk of positive penicillin allergy tests in a french cohort
-
PEN-FAST score performances to evaluate the risk of positive penicillin allergy tests in a french cohort
-
Parasitic Infection as a risk factor for Childhood Asthma in Upper Egypt
-
Past hepatitis B infection as a risk factor for noninfectious mixed cryoglobulinemia vasculitis
-
Patient-Centered Approaches and the Role of Bilastine in long-term Urticaria Management
-
Post-covid immunological sequelae in children – diagnosis and management
-
Practical Guide to Biomarker-Driven Pediatric Asthma Management
-
Prevalence and Risk Factors of Allergic Rhinitis
-
Quercus Pollen Allergy Risk in Alentejo, Portugal, in a climate change scenario
-
Reimagining HAE management in children*
-
Risk Factors for Early Adverse Events of Sublingual Immunotherapy for Allergic Rhinitis and their Impact on Short-term Treatment Outcomes
-
Risk Factors in Breakthrough Reactions during Monoclonal Antibody Desensitization
-
Risk factors for reactions in desensitization to penicillin of pregnant women with syphilis: a Flow chart suggestion
-
Risk factors in Hymenoptera venom allergy (HVA)
-
Risk factors to develop insect venom allergy
-
Role of sublingual immunotherapy in management of patients with moderate to severe allergic rhinitis; one year study
-
Root and branch of childhood asthma management
-
Safety of Single-Dose Drug Provocation Test in Low Risk Non-Immediate Reactions with Beta-Lactam Antibiotics in Children
-
Safety of lanadelumab in an immunosuppressed kidney transplant patient with high cardiovascular risk – a case report
-
Shifting environmental exposures: a call for evolving allergic disease management
-
Simultaneous double drug provocation test in a low risk patient to refute unlikely allergy to paracetamol and ibuprofen
-
Subcutaneous allergen-specific immunotherapy- Safety and risk factors of adverse effects. Data from a tertiary allergy centre
-
Survey of food allergy management in cooking classes at elementary schools
-
Symptomatic management of ISM: Are we doing enough?
-
Telemedicine as an Educational Tool Regarding Anaphylaxis Management for Parents of Children with Food Allergies
-
The Bacterial Lysate 0M-85BV reduces risk for exacerbations and oral corticosteroids in allergic asthma: A retrospective parallel group-controlled study
-
The Effectiveness of Educational Interventions on Asthma Management in Children in Primary care settings: Systematic Review of Randomised Control Trials
-
The Role of Anti-IgE in the Management of Food Allergy
-
The association between specific IgE levels and severity of allergic rhinitis, risk of allergic comorbidities
-
The challenge of chronic urticaria management
-
The expanding field of Primary Atopic Disorders and their management
-
The gut fungome is associated with future risk of exacerbations, asthma control and quality of life in children with uncontrolled asthma: results from the PUFFIN study
-
The use of risk assessment in drug allergy
-
The usefulness of atopy patch tests for the diagnosis and management of children with Non-IgE-mediated gastrointestinal Food Allergy: results of the NIGEFA project
-
The usefulness of atopy patch tests for the diagnosis and management of children with Non-IgE-mediated gastrointestinal Food Allergy: results of the NIGEFA project
-
Turkish National Hereditary Angioedema and Acquired Angioedema Registry, Established to Encourage Standardizing the Care and Management of the Disease. HAE/AAE-TR National Hereditary and Acquired Angioedema Registry Group
-
Unique role of Candida albicans sensitization in management of asthma patients living underground during military operations in Ukraine
-
Using BAT and molecular genetics to determine Hymenoptera anaphylaxis risk
-
Voice biomarkers: a new tool for asthma management
-
Risk stratification in primary care: how to use data to identify people in primary care at risk of harm due to under or over treatment and to prioritise their care
Show more Sessions (140)Show Less-
-
EAACI Launches Second Phase of Groundbreaking Allergy Management Project
-
Explore our EAACI Knowledge Hub Module: Towards precise management of drug allergy
-
Take the EAACI Survey: Exercise and Physical Activity for Asthma Management
-
Take the survey by the EAACI Task Force: Improving Chronic Urticaria Management in Pediatrics – (ICUMP) Management (2)
Show more News (2)Show Less-